Companies /Healthcare

Pfizer Inc

NYSE: PFE Drug Manufacturers - General
$28.28
▲ $0.46 (+1.65%) today
Markets closed · 3:18am ET

PFE Coverage Page 104

5:42am ET
Industrials

GE (GE) Moves To Uncharted Waters Overseas

GE (GE) has been hoping that growth in the developing world would begin to offset slower sales in places like the US and Europe. It may be that they are finally getting…

Douglas A. McIntyre
4:58am ET
Health and Healthcare

Pfizer (PFE): Love Thy Neighbor, Until He Sues You

The Nigerian government is suing Pfizer (PFE) claiming that it "deceived patients and caused the death of 11 children in 1996 when it performed clinical trials for a new drug." According to…

PFE
Douglas A. McIntyre
1:11pm ET
Health and Healthcare

Pfizer (PFE) Not Up On Viagra

A Canadian court ruled that Apotex could not market a generic version of Viagra, Pfizer’s (PFE) massively successful ED drug. Oddly, Pfizer’s shares were down 1.2% to $24.35. The Big Pharma company…

PFE
Douglas A. McIntyre
5:00am ET
Health and Healthcare

Pfizer: Stay On That Lipitor

Patients who swtich from Pfizer’s (PFE) monster selling drug cholesterol pill Lipitor to Merck’s (MRK) Zocor, now available in generic form are more likely to have a heart attack or die. According…

Douglas A. McIntyre
9:19am ET
Investing

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s, one of the most damaging and fastest growing diseases. Pfizer’s (PFE) Lipitor…

Douglas A. McIntyre
8:38am ET
Health and Healthcare

Xoma Gets A Boost

Biopharmaceutical company Xoma (XOMA) is having its luck day. After its stock traded down as low as $2.24, its shares are up almost 20% today on news that it bacterial cell expression…

Douglas A. McIntyre
7:07pm ET
Investing

PFizer’s (PFE) Promising New HIV Drug

Pfizer (PFE) has FDA approval for a new drug that "blocks the CCR5 co-receptor that serves as a main doorway for the HIV virus into immune cells."  It will be marketed as…

PFE
Douglas A. McIntyre
3:27am ET
Investing

NYSE Short Interest For July

Below are key short interest statistics for July. The figures are as of July 13 compared to June 15, 2007 Largest Short Positions Company                         …

Douglas A. McIntyre
7:15am ET
Investing

Pre-Market Stock News (July 18, 2007)

(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items; estimates were $1.08. Spin-off/sale remains on track. (BLK) Blackrock $1.80 EPS vs…

Douglas A. McIntyre
5:59am ET
Health and Healthcare

Pfizer’s (PFE) Bad Hair Day

Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48% to $1.3 billion. The loss of U.S. exclusivity for Zoloft and Norvasc…

PFE
Douglas A. McIntyre